Perkins Capital Management’s Biodesix BDSX Stock Holding History

Perkins Capital Management’s Portfolio BDSX Stock Details BDSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.01M	Sell	44,618 -165	-0.4%	-$2.45K	0.76%	33
2026 Q1	$649K	Hold	44,783	–	–	0.61%	48
2025 Q4	$305K	Sell	44,783 -7,850	-15%	-$57.8K	0.24%	71
2025 Q3	$397K	Sell	52,633 -353	-0.7%	-$2.71K	0.35%	58
2025 Q2	$299K	Hold	52,986	–	–	0.3%	61
2025 Q1	$663K	Sell	52,986 -25	-0%	-$480	0.7%	46
2024 Q4	$1.62M	Buy	53,011 +16,772	+46%	+$493K	1.44%	23
2024 Q3	$1.29M	Buy	36,239 +15,500	+75%	+$533K	1.21%	27
2024 Q2	$635K	Buy	+20,739	New	+$592K	0.6%	52

Other funds holding BDSX

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Perkins Capital Management's BDSX Position: Q2 2026 in Review

Perkins Capital Management reduced its Biodesix (BDSX) stake by 0.37% in Q2 2026, selling an estimated $2.45K and leaving 44,618 shares worth $1.01M. The position accounts for 0.76% of the portfolio, ranked #33.

Perkins Capital Management first reported a position in BDSX in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.62M in Q4 2024. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

Perkins Capital Management held 44,618 shares of Biodesix worth $1.01M as of Q2 2026.
Perkins Capital Management sold 165 Biodesix shares in Q2 2026, an estimated $2.45K.
Biodesix made up 0.76% of Perkins Capital Management's portfolio in Q2 2026, its #33 holding.
Perkins Capital Management first reported a position in Biodesix in Q2 2024 and has held it in 9 quarters since.
Perkins Capital Management's Biodesix position peaked at $1.62M in Q4 2024.
45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Perkins Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.